# TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions

> **NCT01291563** · PHASE1 · COMPLETED · sponsor: **Tibotec BVBA** · enrollment: 88 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** TMC207
- **DRUG:** TMC207 placebo
- **DRUG:** Moxifloxacin placebo

## Key facts

- **NCT ID:** NCT01291563
- **Lead sponsor:** Tibotec BVBA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** —
- **Final completion:** 2011-04
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2012-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291563, "TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01291563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*